PAREXEL International Announces Date of Third Quarter Fiscal Year 2015 Earnings Release and Conference Call
Boston, MA, March 16, 2015 – PAREXEL International Corporation (NASDAQ: PRXL) will release financial results for the Third Quarter of Fiscal Year 2015 on Wednesday, April 29th, 2015 after the close of the stock market. The announcement will be available on PAREXEL’s website at www.PAREXEL.com and on the PRNewswire website at www.prnewswire.com.
PAREXEL will host a conference call and live webcast at 10:00 a.m. EDT on Thursday, April 30th, 2015 to discuss the results. To access the webcast, visit PAREXEL’s website at www.PAREXEL.com, and click on the Investors menu. This webcast will continue to be accessible for one year following the live broadcast. To participate via telephone, dial (408) 940-3886 and ask to join PAREXEL’s Third Quarter Fiscal Year 2015 conference call.
About PAREXEL International
PAREXEL International Corporation is a leading global biopharmaceutical services organization, providing a broad range of expertise-based contract research, consulting, medical communications, and technology solutions and services to the worldwide pharmaceutical, biotechnology and medical device industries. Committed to providing solutions that expedite time-to-market and peak-market penetration, PAREXEL has developed significant expertise across the development and commercialization continuum, from drug development and regulatory consulting to clinical pharmacology, clinical trials management, medical education and reimbursement. PAREXEL Informatics, Inc. provides advanced technology solutions, including medical imaging, to facilitate the clinical development process. Headquartered near Boston, Massachusetts, PAREXEL operates in 81 locations in 51 countries around the world, and has approximately 16,530 employees. For more information about PAREXEL International visit www.PAREXEL.com.
PAREXEL is a trademark or registered trademark of PAREXEL International Corporation or its affiliates.